Heather Dean is the Vice President and Hematology Franchise Head for Takeda’s US Commercial organization. She is responsible for leading the sales and marketing teams for Takeda’s rare hematology portfolio, which currently includes treatments for bleeding disorders such as Hemophilia A, Hemophilia B, and von Willebrand’s Disease. Heather has been with Takeda since 2004, and previously served as VP of Sales and Key Accounts for Takeda’s Gastrointestinal (GI) business unit. Heather’s pharmaceutical experience is focused in the areas of marketing and sales leadership. She began her pharmaceutical career at Eli Lilly and Company in 1999 where she held various commercial positions, launching two diabetes products in sales and a CNS product in marketing. Heather joined Takeda to lead the pre-launch, launch and post-launch phases of the metabolic commercial program. She then went on to head the GI Marketing franchise, which included two primary care GI brands and one pre-launch global specialty GI brand. In 2014, Heather returned to sales as an Area Sales Vice President, leading half of the General Medicine commercial sales organization. Heather holds a Bachelor of Science degree with honors from Northern Illinois University. In 2013, Heather graduated from the Takeda Leadership Institute global leadership development program (through INSEAD). In 2016, Heather was selected to attend the Takeda Global President’s Forum in Tokyo. Heather’s interests include running, Orange Theory classes, involvement in her children’s sports/school activities with her husband, Kevin, and mentoring.